Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Disorders”

14,384 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 14,384 results

Not applicableUnknownNCT06355700
What this trial is testing

Hepatocellular Carcinoma Liver Organoids

Who this might be right for
Hepatocellular Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 10
Not applicableNot Yet RecruitingNCT06787807
What this trial is testing

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Who this might be right for
ObesityColon CancerThyroid Cancer+14 more
Universidade Federal de Pernambuco 103
Post-approval studies (Phase 4)Ended earlyNCT01606800
What this trial is testing

Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 45
Not applicableStudy completedNCT05480007
What this trial is testing

Non-alcoholic Fatty Liver Disease and Its Treatment

Who this might be right for
NAFLD
Shanghai 10th People's Hospital 68
Not applicableUnknownNCT06349044
What this trial is testing

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

Who this might be right for
Her-2 Negative Adenocarcinoma of the Gastro-oesophageal Junction/Gastric AdenocarcinomaHepatocellular CarcinomaBiliary Tract Carcinoma+1 more
Zhejiang Cancer Hospital 120
Not applicableNot Yet RecruitingNCT07820800
What this trial is testing

NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)

Who this might be right for
Type 2 DiabetesCoronary Heart DiseaseMyocardial Infarction+4 more
University of Eastern Finland 1,400
Early research (Phase 1)Study completedNCT01070407
What this trial is testing

A New Candidate Vaccine Against Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
ReiThera Srl 41
Testing effectiveness (Phase 2)Looking for participantsNCT04150744
What this trial is testing

RFA Plus Carrizumab vs Carrizumab Alone for HCC

Who this might be right for
Tumor ImmunityImmunosuppressionRadiofrequency Ablation
Second Affiliated Hospital, Zhejiang University, School of Medicine 120
Large-scale testing (Phase 3)UnknownNCT00610636
What this trial is testing

Treatment Outcomes of Hepatic Metastasis After FOLFOX-4 Therapy

Who this might be right for
Colorectal Cancer
National Taiwan University Hospital 200
Early research (Phase 1)Study completedNCT03132792
What this trial is testing

AFPᶜ³³²T in Advanced HCC

Who this might be right for
Hepatocellular CancerAFP Expressing Tumors
Adaptimmune 39
Testing effectiveness (Phase 2)Study completedNCT04535544
What this trial is testing

JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

Who this might be right for
Hepatitis D, Chronic
Janssen Research & Development, LLC 52
Not applicableUnknownNCT03571711
What this trial is testing

Meropenem Pharmacokinetics in Spontaneous Bacterial Peritonitis

Who this might be right for
Peritonitis BacterialLiver Cirrhosis
Hannover Medical School 15
Not applicableStudy completedNCT00877136
What this trial is testing

A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®

Who this might be right for
Liver TumorsHepatocellular CarcinomaHepatoma+1 more
St. Joseph Hospital of Orange 18
Early research (Phase 1)Study completedNCT06186492
What this trial is testing

Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1)

Who this might be right for
Alpha-1 Antitrypsin Deficiency (AATD)
Wave Life Sciences USA, Inc. 47
Early research (Phase 1)Study completedNCT01144936
What this trial is testing

Study of VX-985 in Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 21
Testing effectiveness (Phase 2)Study completedNCT03917407
What this trial is testing

DUR-928 in Patients With Alcoholic Hepatitis

Who this might be right for
Alcoholic Hepatitis
Craig James McClain 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT05050136
What this trial is testing

Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis

Who this might be right for
Primary Biliary CholangitisPBC
Mirum Pharmaceuticals, Inc. 333
Large-scale testing (Phase 3)Study completedNCT01307436
What this trial is testing

Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines

Who this might be right for
Hepatitis A
Crucell Holland BV 327
Not applicableStudy completedNCT03435536
What this trial is testing

Surgery Impact on Circulating Tumor DNA in Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer
University Hospital, Toulouse 35
Not applicableStudy completedNCT01834300
What this trial is testing

The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non Alcoholic Fatty Liver Disease
University of Liverpool 60
Next Page